Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.05.2011 | Case report

Milnacipran

Neuromuscular and somatosensory disorders in an elderly patient: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Nakagawa S, Okamoto Y, Tsuneto S, Tanimukai H, Goya S, Matsuda Y, Oono Y, Tsugane M, Uejima E.Can milnacipran used for neuropathic pain in patients with advanced cancer cause neuromuscular and somatosensory disorders?. Journal of Palliative Medicine 14: 403-405, No. 4, Apr 2011. Available from: URL: http://dx.doi.org/10.1089/jpm.2010.0485 - Japan Nakagawa S, Okamoto Y, Tsuneto S, Tanimukai H, Goya S, Matsuda Y, Oono Y, Tsugane M, Uejima E.Can milnacipran used for neuropathic pain in patients with advanced cancer cause neuromuscular and somatosensory disorders?. Journal of Palliative Medicine 14: 403-405, No. 4, Apr 2011. Available from: URL: http://​dx.​doi.​org/​10.​1089/​jpm.​2010.​0485 - Japan
Metadaten
Titel
Milnacipran
Neuromuscular and somatosensory disorders in an elderly patient: case report
Publikationsdatum
01.05.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113510-00111

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Iopamidol

Case report

Sunitinib

Case report

Methotrexate